Dyah Aryani, Perwitasari (2008) Telaah pustaka farmakogenetik Antiemetik Antagonis Reseptor 5-hidroksitriptamin 3 dalam onkologi Parmacogenetic of 5 Hydroxytriptamine 3B IN oncology- a review. Jurnal Sains dan Teknologi Farmasi, 13 (2). ISSN 1410 – 0177
|
Text
Jurnal_03.pdf Download (553kB) | Preview |
|
|
Other (Telaah pustaka farmakogenetik Antiemetik Antagonis Reseptor 5-hidroksitriptamin 3 dalam onkologi Parmacogenetic of 5 Hydroxytriptamine 3B IN oncology- a review)
Jurnal_03.ps Download (2MB) | Preview |
Abstract
Nausea and vorniting are the most distressful side effects of cytotoxic drugs in cancer patiens. Anti emetics, such as 5 Hydroxytriptamine 3 reseptor antagonist (5 HT3), dopamine antagonist and neurokinin 1 antagonist are commonly used to reduce these side effect. However, the efficacy of current anticmetics about 70%-80% in cancer patiens treated with hight emetogenic cytotoxic drugs. One of the potential factors explaining this suboptimal response is variability in genes encoding enzymes anda proteins which play a role in metabolism, transport and receptors to anti-emetic drugs, beside other risk factors. This review presents the generic variation of the 5 HT3 reseptor, CYP2D6 anda ATP Binding Casette subfamily B member 1 (ABCB1). Moreover, pharmacogenetic studies exploring associations between genetic variation related to these anti-emetics and offycacy are reviewed. Keyword: anti-emetics, pharmaeogenetics, cancer
| Item Type: | Article |
|---|---|
| Subjects: | R Medicine > RS Pharmacy and materia medica |
| Divisions: | Fakultas Farmasi |
| Depositing User: | Operator Repo Unand |
| Date Deposited: | 30 Mar 2016 03:50 |
| Last Modified: | 30 Mar 2016 03:50 |
| URI: | http://repo.unand.ac.id/id/eprint/1960 |
Actions (login required)
 |
View Item |
